rs4644
| Orientation | plus |
| Stabilized | plus |
| Make rs4644(A;A) |
| Make rs4644(A;C) |
| Make rs4644(C;C) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 14 |
| Position | 55138217 |
| Gene | LGALS3 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs4644 |
| dbSNP (classic) | rs4644 |
| ClinGen | rs4644 |
| ebi | rs4644 |
| HLI | rs4644 |
| Exac | rs4644 |
| Gnomad | rs4644 |
| Varsome | rs4644 |
| LitVar | rs4644 |
| Map | rs4644 |
| PheGenI | rs4644 |
| Biobank | rs4644 |
| 1000 genomes | rs4644 |
| hgdp | rs4644 |
| ensembl | rs4644 |
| geneview | rs4644 |
| scholar | rs4644 |
| rs4644 | |
| pharmgkb | rs4644 |
| gwascentral | rs4644 |
| openSNP | rs4644 |
| 23andMe | rs4644 |
| SNPshot | rs4644 |
| SNPdbe | rs4644 |
| MSV3d | rs4644 |
| GWAS Ctlg | rs4644 |
| GMAF | 0.2925 |
| Max Magnitude | 0 |
| ? | (A;A) (A;C) (C;C) | 28 |
|---|---|---|
|
| ||
[PMID 21396839] Apoptosis gene polymorphisms and risk of prostate cancer: A hospital-based study of German patients treated with brachytherapy
[PMID 21446041
] A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells
[PMID 21475983] Galectin-3 gene (LGALS3) +292C allele is a genetic predisposition factor for rheumatoid arthritis in Taiwan
[PMID 21750908] Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of ?-catenin in gastric cancer
[PMID 22673112] Genetic variation in galectin-3 gene associates with cognitive function at old age
[PMID 19074869] Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study.
[PMID 26312551] Assessment of Galectin-3 Polymorphism in Subjects with Chronic Chagas Disease
[PMID 29152608] Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) Study.
[PMID 30341098] LGALS3 promotes treatment resistance in glioblastoma and is associated with tumor risk and prognosis.
[PMID 33308024] Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system.
